Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
23.45
+0.47 (2.05%)
At close: May 12, 2025, 4:00 PM
23.95
+0.50 (2.13%)
After-hours: May 12, 2025, 7:37 PM EDT
Tandem Diabetes Care Market Cap
Tandem Diabetes Care has a market cap or net worth of $1.56 billion as of May 12, 2025. Its market cap has decreased by -31.57% in one year.
Market Cap
1.56B
Enterprise Value
1.69B
1-Year Change
-31.57%
Ranking
Category
Stock Price
$23.45
Market Cap Chart
Since May 13, 2020, Tandem Diabetes Care's market cap has decreased from $5.04B to $1.56B, a decrease of -69.03%. That is a compound annual growth rate of -20.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.53B | -35.75% |
| Dec 31, 2024 | 2.38B | 22.83% |
| Dec 29, 2023 | 1.93B | -33.19% |
| Dec 30, 2022 | 2.89B | -69.90% |
| Dec 31, 2021 | 9.62B | 60.92% |
| Dec 31, 2020 | 5.98B | 18.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |